(redirected from carcinoid syndrome)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
Related to carcinoid syndrome: Carcinoid tumor
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to carcinoid

a small tumor (benign or malignant) arising from the mucosa of the gastrointestinal tract

Related Words

References in periodicals archive ?
5-8 Historically, well-differentiated neuroendocrine neoplasms have been referred to as carcinoid tumors, a term which may cause confusion because clinically a carcinoid tumor is a serotoninproducing tumor associated with functional manifestations of carcinoid syndrome.
Prognostic value of heart rate variability analysis in patients with carcinoid syndrome.
Carcinoid syndrome is characterized by frequent and debilitating diarrhea that often prevents patients from leading active, predictable lives, as well as by facial flushing, abdominal pain, heart valve damage and other serious consequences.
With echocardiography, tricuspid valve regurgitation is found in 56% of patients with a carcinoid syndrome (3).
The trial showcased the benefit of the oral dose of the investigational drug, telotristat etiprate, in treating cancer patients with carcinoid syndrome.
Consequently, a discussion ensued regarding our original value, and the consultant felt that the index of suspicion for carcinoid syndrome was relatively low.
Pivotal Phase 3 trial for telotristat etiprate in carcinoid syndrome meets primary endpoint
Nasdaq: LXRX) today announced that the pivotal TELESTAR Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome that is not adequately controlled by the current standard of care.
Lexicon has clinical-stage drug programs for diabetes, carcinoid syndrome, and other indications, all of which were discovered by Lexicon's research team.
Telotristat etiprate (LX1032) : Lexicon completed enrollment in TELESTAR, its pivotal Phase 3 clinical trial of telotristat etiprate for patients with carcinoid syndrome.
Euronext: IPN; ADR: IPSEY) today announced that they have entered into an agreement for Ipsen, upon regulatory approval, to commercialize telotristat etiprate in Canada, with a focus on the treatment of carcinoid syndrome.
The effects of carcinoid syndrome are severely debilitating for many people's lives, causing them to suffer from life-altering diarrhea, flushing and pain," said Lonnel Coats, Lexicon's president and chief executive officer.
Nasdaq: LXRX), a biopharmaceutical company focused on developing breakthrough treatments for human disease, today announced that it has completed enrollment in TELESTAR, its pivotal Phase 3 clinical trial of telotristat etiprate for patients with carcinoid syndrome.